Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing ...
In addition to the unprecedented growth of its diabetes and obesity care treatments, Lilly has also secured some major wins ...
Lexaria Bioscience Corp. (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received lead clinical site human research ethics committee (" ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
15h
Generated $50.0 million in net revenue from sales of LUMRYZ™ ----2,300 patients on LUMRYZ as of September 30th, including 700 patients that ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Like Ozempic, Mounjaro is FDA-approved as a diabetes drug. It can help folks with type 2 diabetes ... Most insurance ...
Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.
Fact checked by Nick Blackmer While taking GLP-1 medications like Ozempic may seem like a guaranteed way to reach your weight ...
The Food and Drug Administration told CBS News it cannot comment ... main ingredient semaglutide. FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback